From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notable studies[edit | edit source]
- A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- A study by the Open Medicine Foundation including engineers and biomedical researchers used nanotechnology to create a very small nano-needle that could test blood samples of ME/CFS for the presence of post-exertional malaise by measuring responses when applying a biochemical stress test, including how mitochondria from ME/CFS patients responded compared to samples from healthy people. The idea was to create a new, inexpensive device that could be mass-produced in order to cost-effectively and accurately diagnose ME/CFS patients from a simple blood sample. The technology is still being refined and tested before large scale manufacturing can take place.
See also[edit | edit source]
- List of abnormal findings in chronic fatigue syndrome and myalgic encephalomyelitis
- Biomedical research
- National Institutes of Health funding
Learn more[edit | edit source]
- Press release: Stanford University
- New OMF-funded Research Publication: A Nanoelectronics-blood-based diagnostic biomarker for ME/CFS
- OMF/Ron Davis Research Update - May 2019 (Video)
References[edit | edit source]
- "What Is Biomedical Engineering?". mtu.edu. Retrieved January 31, 2019.
- Moini, Jahangir; Moini, Morvarid (April 7, 2017). Fundamentals of U.S. Health Care: An Introduction for Health Professionals. Taylor & Francis. p. 394. ISBN 978-1-317-21676-6.
- Davis, R.W.; Wilhelmy, J.; Nemat-Gorgani, M.; Kashi, A.; Esfandyarpour, R. (April 25, 2019). "A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)". Proceedings of the National Academy of Sciences. 116 (21): 10250–10257. doi:10.1073/pnas.1901274116. ISSN 0027-8424. PMID 31036648.